In a post hoc analysis of the phase 3 HELIOS-B trial, vutrisiran reduced worsening of left atrial strain at 30 months among patients with transthyretin amyloidosis with cardiomyopathy.
Canadian researchers assessed whether exposure to wildfire-related fine particulate matter was associated with ED visits for migraine and other headaches.
No HIV acquisitions occurred among 315 cisgender and transgender women receiving long-acting cabotegravir PrEP in the real-world US OPERA Cohort, despite mostly short injection delays.
The approval provides a treatment option for adults and adolescents with warm autoimmune hemolytic anemia who are currently or were previously treated with corticosteroids.
August 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a...
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
In 2 phase 3 randomized, placebo-controlled trials of adults and adolescents with nonsegmental vitiligo, once-daily upadacitinib 15 mg significantly improved facial and total-body repigmentation at 48...
In this video, Brittany Albright, MD, discusses why primary care clinicians are often the first line of defense in recognizing and treating anxiety disorders. She reviews practical strategies for screening,...
